What are the benefits and risks of administering oral nutrition versus intravenous fluids in pediatric patients under 24 months receiving HFNC therapy for bronchiolitis?

Read full text Summarise with VIRAT
Authors: Tripdatabase
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Both enteral and intravenous hydration for infants on HFNC therapy in bronchiolitis have benefits and risks. Enteral hydration shows low complication rates and potential improvements in clinical parameters, while IV fluids maintain electrolyte balance but pose practical challenges.

Fields of Study & Subjects

Clinical Nutrition and Gastroenterology Respiratory viral infections research Respiratory Support and Mechanisms

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
13 February 2026
Language
EN